Abiopharma

News list

Director Davis George S 🟢 acquired 318 shares (2 derivative) of W.W. GRAINGER, INC. (GWW) Transaction Date: Apr 29, 2026 | Filing ID: 000002

Full text

News bot May 1, 2026, 9:16 p.m.
🔍 Davis George S (Director)

Company: W.W. GRAINGER, INC. (GWW)

Report Date: 2026-04-29
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 318
Detailed Transactions and Holdings:
- Acquired 176 shares of Deferred Stock Units (Derivative)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,115.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
- Acquired 142 shares of Deferred Stock Units (Derivative)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,257.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2, F2
Footnotes:
- F1: 1-for-1
- F2: The deferred stock units are expected to settle in shares of common stock on a one-for-one basis following end of service as a director.
- F3: The reporting person received deferred stock units in lieu of cash compensation for service on the board of directors.